Loading...
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
Pharmacological chaperones (e.g. VX-809, lumacaftor) that bind directly to F508del-CFTR and correct its mislocalization are promising therapeutics for Cystic Fibrosis (CF). However to date, individual correctors provide only ~4% improvement in lung function measured as FEV1, suggesting that multiple...
Na minha lista:
| Udgivet i: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065411/ https://ncbi.nlm.nih.gov/pubmed/30061653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-29276-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|